Published in Law and Health Weekly, June 24th, 2006
According to recent research published in the journal Anticancer Research, "Anaemia is a common complication of CT, including both non-platinum (Pt)-based as well as Pt-based CT3. Patients from 3 controlled trials with solid tumours receiving either Pt- or non-Pt-based CT, who had been randomised to epoetin beta treatment or standard care, were included in this meta-analysis (n=255, n=199, respectively), to see...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly